Lanctôt, Krista L.

The Pharmacoeconomics of Cognitive Enhancers in Moderate to Severe Alzheimerʼs Disease

Cappell, J., Herrmann, N., Cornish, S., & Lanctôt, K. L. (2010) · CNS Drugs

Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 57

Bias in Peripheral Depression Biomarkers

Carvalho, A. F., Köhler, C. A., Brunoni, A. R., Miskowiak, K. W., Herrmann, N., Lanctôt, K. L., Hyphantis, T. N., Quevedo, J., Fernandes, B. S., & Berk, M. (2016) · Psychotherapy and Psychosomatics

Meta-analysis and systematic reviewsTreatment of Major Depression

Cited by 52

The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis

Dinoff, A., Herrmann, N., Swardfager, W., Gallagher, D., & Lanctôt, K. L. (2018) · Journal of Psychiatric Research

Treatment of Major DepressionPhysical Activity and Health

Cited by 50

Cardiopulmonary Fitness Is Associated with Cognitive Performance in Patients with Coronary Artery Disease

Swardfager, W., Herrmann, N., Marzolini, S., Saleem, M., Kiss, A., Shammi, P., Oh, P. I., & Lanctôt, K. L. (2010) · Journal of the American Geriatrics Society

Cardiac Health and Mental HealthCardiovascular and exercise physiology

Cited by 37

Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults

Diniz, B. S., Vieira, E. M., Mendes‐Silva, A. P., Bowie, C. R., Butters, M. A., Fischer, C. E., Flint, A., Herrmann, N., Kennedy, J., Lanctôt, K. L., et al. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions

Dementia and Cognitive Impairment ResearchTelomeres, Telomerase, and Senescence

Cited by 33

Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis

Lapshin, H., Lanctôt, K. L., O’Connor, P., & Feinstein, A. (2013) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesCancer-related cognitive impairment studies

Cited by 30

Current agents in development for treating behavioral and psychological symptoms associated with dementia

Ahmed, M., Malik, M., Teselink, J., Lanctôt, K. L., & Herrmann, N. (2019) · Drugs & Aging

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 29

Diabetes Mellitus Is Associated With Poor In‐Hospital and Long‐Term Outcomes in Young and Midlife Stroke Survivors

MacIntosh, B. J., Cohen, E., Colby‐Milley, J., Fang, J., Zhou, L., Ouk, M., Wu, C., Shah, B. R., Lanctôt, K., Herrmann, N., et al. (2021) · Journal of the American Heart Association

Acute Ischemic Stroke ManagementNeurological and metabolic disorders

Cited by 17

Novel Phospholipid Signature of Depressive Symptoms in Patients with Coronary Artery Disease

Chan, P., Suridjan, I., Mohammad, D., Herrmann, N., Mazereeuw, G., Hillyer, L. M., Ma, D. W. L., Oh, P. I., & Lanctôt, K. L. (2018) · Journal of the American Heart Association

Cardiac Health and Mental HealthFatty Acid Research and Health

Cited by 15

Gastric acid suppressants and cognitive decline in people with or without cognitive impairment

Wu, C., Xiong, L. Y., Ouk, M., Rabin, J. S., Herrmann, N., Lanctôt, K. L., Kapral, M. K., Law, M., Cogo‐Moreira, H., Edwards, J. D., et al. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 13